Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.73 (
urokinase-type plasminogen activator
)
10,685
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
MTX
peptides in which the amino acid was linked to the alpha-carboxyl group have been prepared and examined for cytotoxicity before and after treatment with proteolytic enzymes. The alanine, aspartic acid and arginine derivatives (
MTX
-ala,
MTX
-asp and
MTX
-arg) were synthesized by a regio-specific route, following the general procedures of Rosowsky and Montgomery. Each compound was obtained in good yield, and purity was established by TLC, HPLC, absorbance spectra and elemental analyses. The
MTX
peptides were not hydrolyzed by a variety of proteolytic enzymes (e.g., trypsin, plasmin,
urokinase
, aminopeptidase). Pancreatic carboxypeptidase A, however, hydrolyzed
MTX
-ala readily,
MTX
-asp slowly and
MTX
-arg not at all. The
MTX
-ala and, to a lesser extent,
MTX
-arg were substrates for pancreatic carboxypeptidase B.
MTX
-arg was also hydrolyzed by the endogenous carboxypeptidase N in human serum. The cytotoxicity of these
MTX
peptides toward L1210 cells was measured in a microculture assay system using a tetrazolium dye.
MTX
-ala was weakly cytotoxic (ID50 = 2.0 x 10(-6)M) compared to
MTX
(ID50 = 2.4 x 10(-8)M). When
MTX
-ala was tested in the presence of carboxypeptidase A, the ID50 value improved to 8.5 x 10(-8)M.
MTX
-arg gave an ID50 of 5.0 x 10(-8)M, which was not unexpected in view of its susceptibility to hydrolysis by the carboxypeptidase activity present in the fetal calf serum of the culture medium. Inclusion of carboxypeptidase B lowered the ID50 value to 2.5 x 10(-8)M. Possible clinical uses of
MTX
peptides are discussed.
...
PMID:Chemotherapeutic potential of methotrexate peptides. 307 29
Pro-UKS1 was designed as a thrombin-resistant derivative of pro-
urokinase
(pro-UK) by introducing a glycosylation site using site-directed mutagenesis. An expression plasmid for pro-UKS1, pMo1UKS1SEd1-5, was constructed and introduced into Namalwa KJM-1 cells (Hosoi et al., 1988), and cells resistant to G418 and
Methotrexate
(
MTX
) were obtained. Amongst them, the highest pro-UKS1 producer (resistant to 500 nM of
MTX
), clone 41-8, was selected and further characterized. Clone 41-8 was cultured in serum-free ITPSGF medium (Hosoi et al., 1988). Under the conventional conditions, the concentration of pro-UKS1 reached 26 micrograms ml-1. Addition of glucose and tri-iodothyronine (T3) improved productivity, and the maximal productivity of pro-UKS1 was 67 micrograms ml-1 day-1. In this conditioned medium, content of pro-UKS1 was above 80% of total proteins.
...
PMID:Stabile production of a thrombin resistant pro-urokinase derivative (PRO-UKS1) by Namalwa KJM-1 cells adapted to serum-free medium. 898 99
Pro-UK delta GS1 was designed as a long-life and thrombin-resistant derivative of pro-
urokinase
(pro-UK) by deleting the growth factor domain of pro-UK and introducing a glycosylation site near the thrombin cleaving site for thrombin-resistance using site-directed mutagenesis. An expression plasmid for pro-UKDGS1, pIH1UK delta GS1SEd1-5 was constructed and introduced into Namalwa KJM-1, a lymphoblastoid cell line adapted to serum-free medium, and cells resistant to G418 and
Methotrexate
(
MTX
) were obtained. Amongst them, the highest pro-UK delta GS1 producer (resistant to 200 nM of
MTX
), clone 2-9, was selected and used for further studies. Under the conventional conditions, i.e. at 37 degrees C in serum-free ITPSGF medium (based on RPMI-1640 medium), the oligosaccharide structure of pro-UK delta GS1 produced by clone 2-9 mainly consisted of fucose (Fuc)-containing biantennary complex-type oligosaccharide. Addition of dexamethasone (Dex), changed the carbohydrate contents in the media, and a shift down of incubation temperature caused a change in oligosaccharide structure of pro-UK delta GS1 from mainly Fuc-containing biantennary to mainly Fuc-containing tri- and tetraantennary complex-type oligosaccharide. The modulated pro-UK delta GS1 showed superior in vivo activity for a canine femoral thrombosis formed by inserting a copper-coil.
...
PMID:Modulation of oligosaccharide structure of a pro-urokinase derivative (pro-UK delta GS1) by changing culture conditions of a lymphoblastoid cell line Namalwa KJM-1 adapted to serum-free medium. 898 1